Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. The ...
Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart disease.
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...